Antoine Awad
Chief Executive Officer bei SYNLOGIC, INC.
Vermögen: 60 608 $ am 31.03.2024
Profil
Antoine Awad is currently the Chief Executive Officer at Synlogic, Inc. He previously worked as the Senior Vice President of Manufacturing & Operations at Abpro Corp., the Head of Process Sciences & Manufacturing at Merrimack Pharmaceuticals, Inc., and the Senior Vice President at L.E.A.F.
Pharmaceuticals LLC.
Mr. Awad completed his undergraduate degree at Boston University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SYNLOGIC INC
0,29% | 02.04.2024 | 33 859 ( 0,29% ) | 60 608 $ | 31.03.2024 |
Aktive Positionen von Antoine Awad
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNLOGIC, INC. | Chief Executive Officer | 18.03.2024 |
Ehemalige bekannte Positionen von Antoine Awad
| Unternehmen | Position | Ende |
|---|---|---|
L.E.A.F. Pharmaceuticals LLC
 L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| ABPRO CORPORATION | Chief Operating Officer | - |
Ausbildung von Antoine Awad
| Boston University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
L.E.A.F. Pharmaceuticals LLC
L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Health Technology |
